William R. Wolter - Concepedia

Concepedia

Author

William R. Wolter

University of Notre Dame

Also Known As

W. R. Wolter, W.R. Wolter, WILLIAM R. WOLTER, William R Wolter, William R. Wolter, William R. Wolter, Wolter, William R.

51

Publications

1.9K

Citations

23

H-Index

110

Concepts

All Affiliations

University of Notre Dame Consejo Superior de Investigaciones Científicas Indiana University – Purdue University Indianapolis Instituto de Química Física Blas Cabrera Cook Biotech (United States)

WR

About

William R. Wolter is an author at University of Notre Dame specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	881
2	Health Sciences	4	4	466
3	Engineering	2	2	44
4	Natural Sciences	1	1	24
5	Public Health	1	1	12

William R. Wolter

×

35

Publications

1.9K

Citations

23

H-Index

	Year	Citations
Acceleration of diabetic wound healing using a novel protease–anti-protease combination therapy Ming Gao, Trung T. Nguyen, Mark A. Suckow, Proceedings of the National Academy of Sciences	2015	172
Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA Patrick R. Gonzales, Mitchell W. Pesesky, Renee A. Bouley, Nature Chemical Biology Antimicrobial Resistance GeneHealth SciencesAntibioticsMedicinePharmacology	2015	163
Structure–Activity Relationship for the 4(3<i>H</i>)-Quinazolinone Antibacterials Renee A. Bouley, Derong Ding, Zhihong Peng, Journal of Medicinal Chemistry	2016	155
Discovery of Antibiotic ( <i>E</i> )-3-(3-Carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3 <i>H</i> )-one Renee A. Bouley, Malika Kumarasiri, Zhihong Peng, Journal of the American Chemical Society	2015	144
Discovery of a New Class of Non-β-lactam Inhibitors of Penicillin-Binding Proteins with Gram-Positive Antibacterial Activity Peter I. O’Daniel, Zhihong Peng, Hualiang Pi, Journal of the American Chemical Society Linezolid-resistant MrsaPenicillin-binding ProteinsAntimicrobial ChemotherapyDrug ResistanceMolecular Pharmacology	2014	141
Validation of Matrix Metalloproteinase-9 (MMP-9) as a Novel Target for Treatment of Diabetic Foot Ulcers in Humans and Discovery of a Potent and Selective Small-Molecule MMP-9 Inhibitor That Accelerates Healing Trung T. Nguyen, Derong Ding, William R. Wolter, Journal of Medicinal Chemistry	2018	132
Targeted Antibiotic Delivery: Selective Siderophore Conjugation with Daptomycin Confers Potent Activity against Multidrug Resistant <i>Acinetobacter baumannii</i> Both in Vitro and in Vivo Manuka Ghosh, Patricia A. Miller, Ute Möllmann, Journal of Medicinal Chemistry Mixed Ligand AnalogAntimicrobial ChemotherapySelective Siderophore ConjugationBacterial Iron TransportDrug Resistance	2017	130
Structure–Activity Relationship for the Oxadiazole Class of Antibiotics Edward Spink, Derong Ding, Zhihong Peng, Journal of Medicinal Chemistry	2015	95
A Chemical Biological Strategy to Facilitate Diabetic Wound Healing Major Gooyit, Zhihong Peng, William R. Wolter, ACS Chemical Biology InflammationDiabetesImmunologyChemical Biological StrategyCell Death	2013	94
The Quinazolinone Allosteric Inhibitor of PBP 2a Synergizes with Piperacillin and Tazobactam against Methicillin-Resistant Staphylococcus aureus Jeshina Janardhanan, Renee A. Bouley, Siseth Martínez‐Caballero, Antimicrobial Agents and Chemotherapy	2019	67

Page 1